MANAGED CARE April 2010. ©MediMedia USA
I-Spy 2 is a new private-public collaboration that combines personalized medicine and novel clinical trial design to develop lifesaving new breast cancer drugs. It’s a partnership between heavy-hitters like the Food and Drug Administration, the National Institutes, and major pharmaceutical companies, and is led by the Foundation for the National Institutes of Health.... About 66 percent of the nearly 20 million state and local government employees were enrolled in employer-sponsored health plans in 2008, according to the Agency for Healthcare Research and Quality. In comparison, only 54 percent of private-sector workers were enrolled in their employers’ health plans.... A Swiss study suggests that implementing antibiotic treatment guidelines to treat infections that commonly occur in hospitals can change prescription practices and increase the appropriate use of antibiotics. The authors suggest that judicious use of antibiotics is essential, considering the growth of antimicrobial resistance and escalating costs in health care.